SBC Medical Group announces $5M share repurchase program

SBCMedicalGroup announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20,2025. Share Repurchase Program: Maximum aggregate amount: US$5million; Implementation period: May20,2025 -May20,2026; Funding source: Surplus cash and future free cash flow. The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic-medical market, and its position as an industry leader. Based on this view, it has decided to purchase shares on the open market at prevailing market prices and the Company will continue to explore additional measures to enhance liquidity of its shares. The Company expects to issue shares as future stock-based compensation in proportion to the number of repurchased shares.